Gemmer Asset Management’s AstraZeneca AZN Stock Holding History

Gemmer Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-376	Closed	-$49K	–	194
2022 Q1	$49K	Hold	376	–	–	0.01%	263
2021 Q4	$44K	Hold	376	–	–	0.01%	306
2021 Q3	$45K	Hold	376	–	–	0.01%	263
2021 Q2	$45K	Hold	376	–	–	0.01%	288
2021 Q1	$37K	Hold	376	–	–	0.01%	312
2020 Q4	$38K	Hold	376	–	–	0.01%	280
2020 Q3	$41K	Hold	376	–	–	0.01%	242
2020 Q2	$40K	Hold	376	–	–	0.01%	232
2020 Q1	$34K	Buy	376 +275	+272%	+$25.9K	0.01%	228
2019 Q4	$10K	Hold	101	–	–	﹤0.01%	646
2019 Q3	$9K	Hold	101	–	–	﹤0.01%	686
2019 Q2	$8K	Hold	101	–	–	﹤0.01%	727
2019 Q1	$8K	Hold	101	–	–	﹤0.01%	770
2018 Q4	$8K	Hold	101	–	–	﹤0.01%	688
2018 Q3	$8K	Hold	101	–	–	﹤0.01%	786
2018 Q2	$7K	Hold	101	–	–	﹤0.01%	852
2018 Q1	$7K	Buy	+101	New	+$7K	﹤0.01%	827

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gemmer Asset Management's AZN Position: Q2 2022 in Review

Gemmer Asset Management sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 376 shares — an estimated $49K sold.

Gemmer Asset Management first reported a position in AZN in Q1 2018 and held it in 17 quarters. The position peaked at $49K in Q1 2022. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

Gemmer Asset Management reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 376 AstraZeneca shares in Q2 2022, an estimated $49K.
Gemmer Asset Management first reported a position in AstraZeneca in Q1 2018 and held it in 17 quarters.
Gemmer Asset Management's AstraZeneca position peaked at $49K in Q1 2022.
1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.